Clinical Trial Update: Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 exploratory trial assessing the efficacy and tolerability of LEO43204 for moderate-to-severe acne (acne vulgaris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• LEO43204

Snippet

Sponsor: LEO Pharma | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2019-02-28